Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Heritage Bio Labs

Research Library

Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.

Browse by productGeneral topics

Find articles

All articles

Showing 133–144 of 411 articles

  • Interpret the evidence

    How a cultured pituitary study separated receptor signals

    GHRP-2 is a six-residue synthetic peptide also called pralmorelin. It activates the ghrelin receptor, also known as the growth hormone secretagogue receptor. How did researchers distinguish its signaling from that of the natural pituitary stimulus growth hormone–releasing hormone (GHRH)?

    GHRP-22 sources (1998, 2025)

  • Interpret the evidence

    What the 2026 COURAGE-2 stroke trial found about a specific combination

    Growth hormone–releasing peptide 6, or GHRP-6, is a synthetic six-residue peptide that activates the ghrelin receptor and can stimulate growth hormone release. In 2026, a clinical trial reported whether a combination containing GHRP-6 improved disability after acute ischemic stroke.

    GHRP-62 sources (2021, 2026)

  • Check methods and identity

    What a rat stroke experiment measured in tissue near the injury

    GHRP-6 is a six-residue synthetic growth hormone secretagogue and ghrelin-receptor agonist. A 2026 animal study examined the proteins that changed after GHRP-6 and epidermal growth factor (EGF) were given together in a stroke model.

    GHRP-63 sources (2021, 2026)

  • Understand the science

    How a 2026 experiment studied cardiac remodeling after a blocked artery

    GHRP-6, short for growth hormone–releasing peptide 6, is a six-residue peptide that activates the ghrelin receptor. In March 2026 researchers reported what happened when they studied GHRP-6 after a coronary artery was permanently blocked in rats.

    GHRP-62 sources (2021, 2026)

  • Understand the science

    How a six-residue peptide can fit the ghrelin receptor

    GHRP-6 is a synthetic six-residue growth hormone–releasing peptide that activates the ghrelin receptor. How can it activate the same receptor as ghrelin, a longer natural hormone with a different chemical structure?

    GHRP-61 source (2021)

  • Explore study findings

    Why preventing a raised scar differs from reversing one

    GHRP-6 is a synthetic six-residue peptide that activates the ghrelin receptor and promotes growth hormone release in experimental settings. An animal study asked whether exposure to GHRP-6 changed the development of a raised scar or the appearance of an already mature scar.

    GHRP-62 sources (2018, 2021)

  • Explore study findings

    Why a human blood study reported two half-lives

    GHRP-6 is a six-residue synthetic growth hormone–releasing peptide. In a small human study, researchers asked which mathematical model best described the decline of GHRP-6 itself in blood. No recent primary human study directly repeating this time-course experiment was identified.

    GHRP-61 source (2012)

  • Check methods and identity

    Why the GLOW Name Does Not Identify a Single Peptide

    GLOW is a catalog name for a blend, rather than the name of one defined peptide. The formulation discussed here refers to three named components: GHK-Cu, BPC-157 and material labeled TB-500.

    GLOW Blend3 sources (2026)

  • Interpret the evidence

    What an Achilles Tendon Study Can Tell Us About Two GLOW Components

    GLOW is a blend label that can include BPC-157, a material called TB-500 and GHK-Cu. A 2026 study addresses the first two names in a rat model, which makes it useful for understanding the component evidence. The experiment did not test the three-component GLOW mixture.

    GLOW Blend2 sources (2026)

  • Explore study findings

    Why Copper’s Chemical Form Matters When Reading GLOW Research

    Peptides are short chains made by linking amino acids through peptide bonds. A chain can sometimes bind a metal ion. That is the case for GHK-Cu, the copper complex of a three-amino-acid peptide and one ingredient named in descriptions of GLOW.

    GLOW Blend1 source (2026)

  • Explore study findings

    What a Copper Peptide Hydrogel Study Adds to the GLOW Discussion

    GLOW is a label for a mixture of research materials that can include GHK-Cu, a peptide bound to copper. A 2026 paper used GHK-Cu in an engineered hydrogel for an infected diabetic wound model.

    GLOW Blend1 source (2026)

  • Understand the science

    How to Read a Claim That GLOW Ingredients Work Better Together

    GLOW is a label sometimes used for material containing GHK-Cu, BPC-157 and TB-500. A claim that the ingredients work better together requires a comparison of the actual blend with the relevant components. Separate papers about different tissues and endpoints do not make that comparison.

    GLOW Blend2 sources (2026)

Browse by product

General topics

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Library index (JSON)